S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The "King Of Quants" sees 10X potential... (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The "King Of Quants" sees 10X potential... (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The "King Of Quants" sees 10X potential... (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
5 Best Dividend Capture Stocks
The "King Of Quants" sees 10X potential... (Ad)
These 3 Chip Stocks May Be Approaching A Buy Point Soon
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Dividend King Genuine Parts Company Upgraded On Profit Guidance
11 Best Consumer Discretionary Stocks of 2023
Forbes mag says this strategy "like finding money in the street" (Ad)pixel
The Bottom Is In For Accenture
14 Best Consumer Staples Dividend Stocks
NASDAQ:NVCR

NovoCure - NVCR News Today

$57.17
+0.36 (+0.63%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$56.06
$57.64
50-Day Range
$56.44
$95.09
52-Week Range
$56.06
$120.03
Volume
561,258 shs
Average Volume
1.09 million shs
Market Capitalization
$6.03 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$87.33
Get NovoCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter.


NVCR Media Mentions By Week

NVCR Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

NVCR
News Sentiment

0.18

0.52

Average
Medical
News Sentiment

NVCR News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

NVCR Articles
This Week

5

3

NVCR Articles
Average Week

SourceHeadline
marketbeat.com logoArmstrong Advisory Group Inc. Purchases New Shares in NovoCure Limited (NASDAQ:NVCR)
marketbeat.com - March 24 at 6:23 AM
marketbeat.com logoNovoCure Limited (NASDAQ:NVCR) Shares Sold by Peregrine Capital Management LLC
marketbeat.com - March 20 at 5:47 AM
MarketBeat logoJPMorgan Chase & Co. Reaffirms "Underweight" Rating for NovoCure (NASDAQ:NVCR)
americanbankingnews.com - March 20 at 3:36 AM
finance.yahoo.com logoInstitutional investors may adopt severe steps after NovoCure Limited's (NASDAQ:NVCR) latest 7.3% drop adds to a year losses
finance.yahoo.com - March 16 at 3:41 PM
finance.yahoo.com logoNovocure Announces Reimbursement of Optune® for the Treatment of Newly Diagnosed Glioblastoma in France
finance.yahoo.com - March 1 at 12:07 PM
finance.yahoo.com logoNovoCure Full Year 2022 Earnings: US$0.88 loss per share (vs US$0.56 loss in FY 2021)
finance.yahoo.com - February 24 at 7:39 AM
finance.yahoo.com logoNovoCure Full Year 2022 Earnings: US$0.88 loss per share (vs US$0.56 loss in FY 2021)
finance.yahoo.com - February 24 at 7:39 AM
finance.yahoo.com logoWhy NovoCure Stock Is Falling Today
finance.yahoo.com - February 23 at 4:37 PM
finance.yahoo.com logoShould You Investigate NovoCure Limited (NASDAQ:NVCR) At US$87.50?
finance.yahoo.com - February 10 at 5:58 AM
finance.yahoo.com logoNovocure Round-Trips Its Recent Breakout After Announcing A Series Of C-Suite Changes
finance.yahoo.com - January 19 at 3:10 PM
finance.yahoo.com logoNovocure Has Fallen More Than 20% Over Seven Days — Why It Fell From Grace
finance.yahoo.com - January 17 at 1:29 PM
finance.yahoo.com logoWhy Novocure Stock Is Flying High
finance.yahoo.com - January 6 at 8:16 AM
finance.yahoo.com logoNovocure Skyrockets 69% After Pulling Off A Once-In-Six-Years Feat
finance.yahoo.com - January 5 at 7:54 PM
finance.yahoo.com logoWhy Novocure Stock Is Skyrocketing Today
finance.yahoo.com - January 5 at 2:49 PM
finance.yahoo.com logoNovocure to Participate in 41st Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 27 at 8:32 AM
finance.yahoo.com logoIs NovoCure Limited (NASDAQ:NVCR) Worth US$74.7 Based On Its Intrinsic Value?
finance.yahoo.com - November 30 at 11:49 AM
finance.yahoo.com logoNovocure Stock: Bull vs. Bear
finance.yahoo.com - November 26 at 6:12 AM
finance.yahoo.com logoNovocure Opens Office in Montreal to Expand and Support Growing Business in Canada
finance.yahoo.com - November 15 at 9:39 AM
finance.yahoo.com logoNovocure Secures CE Mark for New Array
finance.yahoo.com - November 11 at 1:02 PM
finance.yahoo.com logo2 Potentially Explosive Stocks to Buy in November
finance.yahoo.com - November 8 at 1:50 PM
msn.com logoNovoCure's Return On Capital Employed Insights
msn.com - November 4 at 1:37 PM
finance.yahoo.com logoNovoCure (NVCR) Reports Q3 Loss, Lags Revenue Estimates
finance.yahoo.com - October 27 at 6:06 PM
finance.yahoo.com logoNovocure (NVCR) Q3 2022 Earnings Call Transcript
finance.yahoo.com - October 27 at 6:06 PM
seekingalpha.com logoNovoCure downgraded at Piper Sandler despite positive Phase 3 readout ahead
seekingalpha.com - October 25 at 1:10 PM
finance.yahoo.com logoWhy Novocure Stock Is Sinking Today
finance.yahoo.com - October 24 at 9:12 PM
finance.yahoo.com logoNovoCure (NASDAQ:NVCR) shareholders have earned a 30% CAGR over the last five years
finance.yahoo.com - October 23 at 7:43 PM
nasdaq.com logo3 Unstoppable Stocks You Can Buy Now for Less Than $100 - Nasdaq
nasdaq.com - October 13 at 10:57 AM
nasdaq.com logoThe Clock Is Ticking to Buy This Game-Changing Stock at a Discount - Nasdaq
nasdaq.com - October 6 at 10:17 AM
finance.yahoo.com logoThe Clock Is Ticking to Buy This Game-Changing Stock at a Discount
finance.yahoo.com - October 6 at 10:17 AM
finance.yahoo.com logoNovocure to Report Third Quarter 2022 Financial Results
finance.yahoo.com - October 3 at 8:15 AM
seekingalpha.com logoNovoCure: See Past Market Myopia And Buy The Dip (NASDAQ:NVCR) - Seeking Alpha
seekingalpha.com - September 27 at 8:40 PM
nasdaq.com logoNVCR Makes Notable Cross Below Critical Moving Average - Nasdaq
nasdaq.com - September 23 at 9:45 AM
benzinga.com logoNovoCure Whale Trades For September 21 - NovoCure (NASDAQ:NVCR) - Benzinga
benzinga.com - September 21 at 6:57 PM
businesswire.com logoNovocure Announces Creation of U.S. CNS Cancers Franchise Intended to Renew Focus on Growth in Glioblastoma Business - Business Wire
businesswire.com - September 21 at 10:03 AM
finance.yahoo.com logoNovocure Announces Creation of U.S. CNS Cancers Franchise Intended to Renew Focus on Growth in Glioblastoma Business
finance.yahoo.com - September 21 at 10:03 AM
realmoney.thestreet.com logoNovoCure Appears Poised for an Upside Breakout - RealMoney
realmoney.thestreet.com - September 14 at 11:01 PM
investors.com logoNovocure Earns Relative Strength Rating Upgrade - Investor's Business Daily
investors.com - September 12 at 10:54 AM
finance.yahoo.com logoUPDATE 1-Ivory Coast sells 2023/24 cocoa contracts with positive origin differential - Yahoo Finance
finance.yahoo.com - September 12 at 10:54 AM
finance.yahoo.com logoAfter losing 33% in the past year, NovoCure Limited (NASDAQ:NVCR) institutional owners must be relieved by the recent gain
finance.yahoo.com - September 12 at 10:54 AM
finance.yahoo.com logoNovoCure Appears Poised for an Upside Breakout
finance.yahoo.com - September 12 at 10:54 AM
finance.yahoo.com logoAlpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer - Yahoo Finance
finance.yahoo.com - September 1 at 10:36 PM
streetinsider.com logoAlpha Tau Appoints Industry Veteran Peter Melnyk as Chief Commercial Officer - StreetInsider.com
streetinsider.com - September 1 at 5:34 PM
finance.yahoo.com logoNovocure to Participate in Upcoming Investor Conferences - Yahoo Finance
finance.yahoo.com - September 1 at 3:30 AM
businesswire.com logoNovocure to Participate in Upcoming Investor Conferences - Business Wire
businesswire.com - August 31 at 12:02 PM
finance.yahoo.com logoNovocure to Participate in Upcoming Investor Conferences
finance.yahoo.com - August 31 at 12:02 PM
fool.com logoWhy I Own Novocure Stock (NVCR) - The Motley Fool
fool.com - August 22 at 11:45 AM
finance.yahoo.com logoWhy I Own Novocure Stock (NVCR)
finance.yahoo.com - August 22 at 11:45 AM
globenewswire.com logoRich Insights Into The Robust Metastatic Melanoma Clinical Trials Pipeline Analysis Featuring 75+ Companies DelveInsight - GlobeNewswire
globenewswire.com - August 18 at 2:50 PM
businesswire.com logoNovocure Hosts U.S. Sen. Maggie Hassan at Company's Portsmouth Facility - Business Wire
businesswire.com - August 10 at 1:06 PM
nasdaq.com logoThe Chief Medical Officer of NovoCure Limited (NASDAQ:NVCR), Ely Benaim, Just Sold 89% Of Their Holding
nasdaq.com - August 8 at 1:44 PM
msn.com logoNovoCure Earnings Perspective: Return On Capital Employed
msn.com - August 4 at 1:34 PM
fool.com logo5 Top Stocks for August - The Motley Fool
fool.com - August 1 at 4:47 AM
Get NovoCure News Delivered to You Automatically

Sign up to receive the latest news and ratings for NVCR and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:NVCR) was last updated on 3/25/2023 by MarketBeat.com Staff